Crossmatch procedures used in organ transplantation.
Several lymphocyte crossmatch procedures used in clinical histocompatibility laboratories, including complement dependent (CDC, AHG-CDC) and complement independent (flow cytometric, chromium release) techniques, are used to assess the likelihood of allograft rejection due to preformed donor specific antibody. Crossmatch assays can be extremely sensitive and detect very low levels of donor reactive antibody present in the potential recipient. Since positive crossmatches are usually associated with allograft rejection, a positive crossmatch is generally a contraindication to organ transplantation. Recent data, however, suggests that not all positive crossmatches lead to graft rejection, particularly those due to autoantibodies. This underscores the need to critically evaluate any positive crossmatch to determine if the antibodies involved in the reaction are relevant to allograft rejection.
Gebel
H M
HM
Department of Immunology/Microbiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois.
Lebeck
L K
LK
D002860:Chromium Radioisotopes; D003165:Complement System Proteins / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D005434:Flow Cytometry; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D007114:Immunization; D008214:Lymphocytes / Q000276:immunology; D014019:Tissue Donors; D014181:Transplantation Immunology
D002860:Chromium Radioisotopes; D003165:Complement System Proteins